Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Sponsors and patients press for caps on insulin and epinephrine costs; students and advocates testify
Summary
Representative Sean Boucher presented House Bill 1195 to address high consumer costs for insulin and epinephrine auto-injectors; students, patients and advocacy groups testified in support, citing national price hikes, rationing and state models in other states; insurers asked for technical work with sponsors.
Representative Sean Boucher (presenting as sponsor) told the committee House Bill 1195 aims to curb what he called “excessive rise in cost for life-saving drugs of insulin and epinephrine.” He said insulin prices have tripled over the past decade and that many patients ration insulin or skip fills when costs compete with rent or utilities.
Patient witnesses and student advocates emphasized the human toll. Multiple student speakers from Saint Louis University Health Policy Pod and family members told the committee about…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
